EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment

Vineela Parvathaneni iD, Snehal K Shukla, Vivek Gupta iD

Pharmaceutics · 20.03.2023 · 15 (3) · 1001

DOI: 10.3390/pharmaceutics15031001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 20.03.2023. Verfasst von Vineela Parvathaneni und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Pharmacy and Health Sciences (CPHS), St. John’s University, Doctoral Fellowship offered by the College of Pharmacy and Health Sciences at St. John’s University, NIH Academic Research Enhancement Award (R15).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this study was to construct amodiaquine-loaded, folic acid-conjugated polymeric nanoparticles (FA-AQ NPs) to treat cancer that could be scaled to commercial production. In this study, folic acid (FA) was conjugated with a PLGA polymer followed by the formulation of drug-loaded NPs. The results of the conjugation efficiency confirmed the conjugation of FA with PLGA. The developed folic acid-conjugated nanoparticles demonstrated uniform particle size distributions and had visible spherical shapes under transmission electron microscopy. The cellular uptake results suggested that FA modification could enhance the cellular internalization of nanoparticulate systems in non-small cell lung cancer, cervical, and breast cancer cell types. Furthermore, cytotoxicity studies showed the superior efficacy of FA-AQ NPs in different cancer cells such as MDAMB-231 and HeLA. FA-AQ NPs had better anti-tumor abilities demonstrated via 3D spheroid cell culture studies. Therefore, FA-AQ NPs could be a promising drug delivery system for cancer therapy.

Schlagwörter

Stichwörter der Autor:innen

3D spheroid studiesamodiaquinecancerfolic acidnano-repurposingnanoparticlesrepurposingtargeted delivery

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.

ORCID-Profile: Vineela Parvathaneni, Vivek Gupta

Förderung

  • College of Pharmacy and Health Sciences (CPHS), St. John’s University
  • Doctoral Fellowship offered by the College of Pharmacy and Health Sciences at St. John’s University
  • NIH Academic Research Enhancement Award (R15)

Zitieren

APA

Parvathaneni, V., Shukla, S. K., & Gupta, V. (2023). Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment. Pharmaceutics, 15(3), 1001. https://doi.org/10.3390/pharmaceutics15031001

Vancouver

Parvathaneni V, Shukla SK, Gupta V. Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment. Pharmaceutics. 2023;15(3):1001. doi:10.3390/pharmaceutics15031001

BibTeX
@article{Parvathaneni2023,
  author = {Parvathaneni, Vineela and Shukla, Snehal K and Gupta, Vivek},
  title = {Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {1001},
  doi = {10.3390/pharmaceutics15031001}
}
Kostenlos starten →